Surgalign, Aziyo Biologics seal cell bone matrix distribution deal

Aziyo Biologics is providing spine device company Surgalign Holdings with its ViBone Moldable cell bone matrix for distribution in the U.S.

Advertisement

ViBone Moldable joins Surgalign’s list of bone graft products to support spinal fusion.

The orthopedic repair market is projected “to be a $2 billion market opportunity, with 1.5 million annual orthopedic and spinal repair procedures using biologic materials,” Aziyo President and CEO Ron Lloyd said in a Nov. 17 news release.

Surgalign strengthened its presence in the spine market in October after it acquired Holo Surgical, which is developing an augmented reality surgical navigation system.

More articles on devices:
The most controversial trends in spine from 10 surgeons
6 Texas orthopedic practices to merge into 150-plus physician group
We’re going to need a bigger scalpel — Mississippi spine surgeon operates on sand tiger shark’s spine

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.